title: Nuclear organization of centromeric domains is not perturbed by inhibition of histone deacetylases.
abstract: It is well established that modification of lysines in histone molecules correlates with gene expression and chromatin structure. It is not known whether this operates entirely at a local level, e.g. through the recruitment of specific proteins, or whether histone modifications might impact on more long-range aspects of chromatin organization. There is a distinctive organization of chromatin within the nucleus and the chromatin at the nuclear periphery of mammalian cells appears to be hypoacetylated. Previously it had been suggested that inhibition of histone deacetylases by TSA causes a gross remodeling of nuclear structure, specifically the recruitment of centromeric heterochromatin to the nuclear periphery. Here, we have quantified the nuclear organization of histone modifications and the localization of centromeric domains in human cells before and after TSA treatment. TSA alters the nuclear distribution of histone acetylation, but not that of histone methylation. TSA elevates levels of histone acetylation at the nuclear periphery but we see no alteration in the position of centromeric domains in the nuclei of treated cells. We conclude that the distinctive nuclear localization of centromeric domains is independent of histone acetylation.
authors.affiliation: MRC Human Genetics Unit, Crewe Road, Edinburgh EH4 2XU, UK.
authors.forename: Susan
authors.initials: S
authors.lastname: Gilchrist
authors.forename: Nick
authors.initials: N
authors.lastname: Gilbert
authors.forename: Paul
authors.initials: P
authors.lastname: Perry
authors.forename: Wendy A
authors.initials: WA
authors.lastname: Bickmore
mesh_terms: D000107:Acetylation / Q000187:drug effects; D002467:Cell Nucleus / Q000201:enzymology / Q000378:metabolism / Q000648:ultrastructure; D002503:Centromere; D005347:Fibroblasts / Q000166:cytology / Q000276:immunology; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000378:metabolism; D006657:Histones / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D008745:Methylation
chemical_list: D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; C012589:trichostatin A; D006655:Histone Deacetylases